Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEETINGS - American College of Surgeons holds Annual Spring Meeting (US) April - May 2000:

This article was originally published in Clinica

Executive Summary

The American College of Surgeons (ACS) will hold its 28th Annual Spring Meeting in Washington, DC, US on April 30-May 3. Topics for discussion include: image-guided breast biopsy; surgical education: principle and practice; ultrasound for surgeons; minimal access surgery: a mature perspective; breast ultrasound; ultrasound in the acute setting; vascular surgery, 2000; vascular ultrasound; stereotactic breast biopsy; new directions in cancer care; and difficult operative approaches in the trauma patient. For more information contact ACS in the US. Tel: +1 312 202 5000. Fax: +1 312 202 5001.

You may also be interested in...



Gene Therapy Approvals By US FDA Could Double In 2020

CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.

Topics

UsernamePublicRestriction

Register

MT075722

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel